A Feasibility Assessment and a Phase I/II Trial of MLN518 for Treatment of Patients with Recurrent Glioblastoma

Grant

Date/time Interval

  • August 25, 2010 - August 24, 2011
  • Total Award Amount

  • 3000.00
  • Direct Costs

  • 2381.00
  • Sponsor Award Id

  • NABTT0504
  • Contributor

  • Nabors M.D., Louis   Principal Investigator